Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Synthesis of multiple antigenic peptides | LifeTein Peptide Blog

Synthesis of multiple antigenic peptides: strategies and limitations Dendrimeric platforms such as MAPs can be synthesized by a solid phase method or by conjugation. Dendrimeric platforms such as MAPs can be synthesized either entirely by solid-phase methods (

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Synthesis of multiple antigenic peptides: strategies and limitations

Dendrimeric platforms such as MAPs can be synthesized by a solid phase method or by conjugation. Dendrimeric platforms such as MAPs can be synthesized either entirely by solid-phase methods (SPPS, direct approach) or by conjugation in a solution of preformed, SPPS-made building blocks (indirect approach).

https://www.ncbi.nlm.nih.gov/pubmed/21391284

SPPS is the preferred method by LifeTein. The synthesis approach requires a branched poly-lysine core. Each branch is elongated into the corresponding epitope by stepwise SPPS. The disadvantage of this approach is that synthetic errors could happen and cause microheterogeneity in the final materials. However, the cost is lower and less time-consuming than the indirect approach. For very long linear peptides, it is more advantageous to use the SPPS method.

The MAP synthesis may not always meet with success. The solubility of the peptide epitope can also become an issue and is difficult to predict for long epitopes. It is recommended to carefully design and analyze the linear epitope before MAP synthesis.

Studies showed that synthesis with Ahx linker in the lysine core had a better-isolated yield. It is possible that the flexibilities of Ahx help in keeping peptide chains properly solvated during synthesis, preventing aggregation, and hence increasing the amount of viable growing peptide sequences.

Peptide-protein interactions Did you know that 15%–40% of all interactions in the cell are mediated through protein-peptide interactions? The following peptide designs are powerful strategies to learn about the general features of optimal peptide sequences binding to a given domain or protein.

Enhanced solubility: Analyze charged residues for better solubility.

Control peptides: Scrambled peptide as a control.

CPP peptide: TAT sequence for cell penetration.

Spacer or Linker: A GG, or PEG linker to increase flexibility.

D amino acid peptide: Avoid degradation.

Biotin conjugation: Biotin/avidin of pull-down assay for your target.

https://lifetein.com/Peptide-Synthesis-Biotin-Peptides.html

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Structural Studies

Rigid spacers help stabilize peptide conformations in NMR or crystallography studies, providing more precise structural data.Find out more about peptide synthesis here.

Source: lifetein.com ↗

Can I purchase custom FAM-labeled peptides for my research?

Yes. Specialized providers such as LifeTein offer custom synthesis of FAM-labeled peptides with high purity (>98%) and rigorous analytical validation. Their services include choices between 5-FAM and 6-FAM, optional spacers (Ahx, β-Ala), and a variety of conjugation positions (N-terminus, lysine side chain, cysteine-specific labeling).

Source: lifetein.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to solubilize my synthetic peptides? #

Please refer to this FAQ for details: Handling and Storage of Synthetic Peptides. If the peptides are still cloudy, or turbid, you may have reached the limit of solubility. When the peptides are insoluble in the buffer, please try to sonicate, centrifuge, and lyophilize the peptide. Make sure to break the lyophilized lumps into a fine powder. Then try a small volume of a good agent 8M Urea, NMP, DMF, or DMSO to dissolve the peptide. Then dilute with water or your desired buffer. For peptides with Arg or LYs, you should try to lower the pH to 6 because the protonated amino acids will help solubility. Sonication and the following solvents may help with difficult peptides: 1) Begin with 100 % acetonitrile then dilute with water until 50% 2) Begin with 100% DMSO then dilute with water until 30 % 3) Dissolve it with 8M Urea 4) Dissolve it with 6 or 8 M Guanidine hydrochloride 5) 6M GuHCL, 0.05% TFA, pH2, 6) 100% TFA 7) 40% AcOH, 30%ACN, 30% water

Source: lifetein.com ↗
Storage reference

Q2: What is the recommended storage condition for labeled peptides?

A: Store labeled peptides at –20°C in the dark. Components B-D should be stored at 2–6°C.

Source: lifetein.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →